Ferreira, Natália S.
Mathias, Jéssica Lorena S.
Albuquerque, Sérgio Roberto L.
Almeida, Anne Cristine G.
Dantas, Ana C.
Anselmo, Fernanda C.
Lima, Emerson S.
Lacerda, Marcus Vinicius G.
Nogueira, Paulo A.
Ramasawmy, Rajendranath
Gonçalves, Marilda S.
Moura Neto, José P.
Funding for this research was provided by:
fundação de amparo à pesquisa do estado do amazonas (1094/2013)
conselho nacional de desenvolvimento científico e tecnológico
Article History
Received: 31 July 2021
Accepted: 20 April 2022
First Online: 8 May 2022
Declarations
:
: This research was initiated after approval by the Research Ethics Committee (CEP) at FMT-HVD. To ensure patient welfare, all the patients included in the study signed the informed consent form (ICF), in compliance with CNS Resolutions 196/96.The samples were from a larger study entitled “Clinical characterization of malaria complicated by <i>Plasmodium vivax</i>”, approved by the National Commission for Ethics in Research (CONEP), in June 2009, opinion No. 343/2009, protocol No. 25.000.011.792/2009–15. This new project was approved by the Research Ethics Committee at FMT-HVD (study number 343/2009) entitled “Study of DUFFY polymorphisms in patients infected with <i>Plasmodium vivax</i>” under approval No. CAAE-0004.0.112.000–11 on 12/29/2011.
: Not applicable.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.